QTTB
Q32 Bio Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-10
Figures on this page computed 2026-11-08 12:33 UTC
Last close
8.97USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-10
3.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-10
186.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-05
55.5%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
-62.4%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
0.37Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-05
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth81.8%94 of 100, above its sector
- Returns on capital186.5%99 of 100, above its sector
- Margins31.4%69 of 100, above its sector
- Price3.8x68 of 100, above its sector
- Safety0.3761 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Against its rival
lens 4 of 9Measure by measure
behind on 0 of 2- Profit on each unit of sales55.5%-18.2%Ahead
Higher is better here.
- Return on the capital it uses187%n/an/a
Higher is better here.
- Sales growth over five years81.9%-19.0%Ahead
Higher is better here.
- Debt against equity0.37n/an/a
Lower is better here.
- Gross marginn/a56.6%n/a
Higher is better here.
- Price against earnings3.8xn/an/a
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Amarin Corporation plc, QTTB is behind on 0 of 2 measures.
Against Amarin Corporation plc, QTTB is behind on 0 of 2 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-03-10
Profit on each unit of sales55.5%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
Return on the capital it uses186.5%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
Sales growth over five years81.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
Debt against equity0.37
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
Gross marginn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD
Price against earnings3.8x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001193125-26-099339
- Reported in
- USD